Skip to main content
FacebookFacebookFacebook
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Technologies-homepage banner.jpg
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    ICON Biotech website mega nav.png
    Biotech

    Developing transformative therapies requires a flexible approach.

    icon-and-you-mdd.jpg
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    cells-menu-hero.jpg
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    icons connected through network_artificail_intelligence
    Decoding AI in software as a medical device (SaMD)

    Regulatory insights and market strategies.

    digital_numbers_data
    The claims conundrum

    Integrating openness and precision for competitive advantage.

    digital_AI_artificial_intelligence
    Integrating AI into clinical research

    How AI is enhancing clinical development.

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    old_woman
    Get ready for a new wave of clinical trials in Schizophrenia

    16 June 2025. Register now.

    laptop_with_graph
    A Deep Dive into Claims Data Innovation

    18 June 2025. Register now.

  • About ICON
    About ICON
    Company history ICON at a glance Healthcare Intelligence ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    esg-mdd.jpg
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    healthcare-intelligence-video-poster.png
    Healthcare Intelligence

    Clinical Research. Evolved.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. News & Events

ICON portfolio of AI tools drives clinical trial efficiencies

Enterprise Ireland grant awarded to ICON to further enhance artificial intelligence capabilities

Read the press release

Biomarker and trial optimisation needed to drive R&D progress in Alzheimer’s and related disorders

ICON survey

Read the press release

ICON and its employees celebrated for excellence in the field of clinical research

Read the press release

Press releases

ICON_Dublin-Reception
  • 14 August 2024

ICON announces appointment of new Chief Financial Officer (CFO)

icon-dublin-office-headquarters
  • 24 July 2024

ICON reports second quarter 2024 results

icon-dublin-office-hq-building
  • 24 July 2024

ICON announces results of Annual General Meeting and changes to the Board of Directors

ICON_Dublin-Reception
  • 10 July 2024

ICON recognised for leadership position in clinical research industry and as socially responsible employer

icon-dublin-office-headquarters
  • 01 July 2024

ICON plc schedules second quarter 2024 earnings conference call

icon-dublin-office-hq-building
  • 04 June 2024

ICON plc to present at the Jefferies Global Healthcare conference

ICON_Dublin-Reception
  • 30 May 2024

ICON hosts investor day and updates full year 2024 financial guidance

icon-dublin-office-headquarters
  • 20 May 2024

ICON plc to hold Investor Day meeting on May 30, 2024

icon-dublin-office-hq-building
  • 08 May 2024

ICON releases its ICON Cares 2023 Report

reception-at-icon-hq-dublin-ireland
  • 30 April 2024

ICON announces pricing of USD 2 billion notes

Events

digital_network
  • 9 July 2025

Network meta-analysis and its role in evidence-based decision-making

Awards

Awards

press-office

ICON Press office enquiries

Videos

Videos

media-articles

Media articles

What’s happening in ICON

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2025 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence